Dennis A Steindler. Show Affiliations »
Abstract
Mesh： See more » 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/administration & dosage1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/analogs & derivativesAnimalsBiocompatible MaterialsCell SurvivalDextroamphetamine/pharmacologyFemaleHypoxia-Ischemia, Brain/complicationsHypoxia-Ischemia, Brain/pathologyHypoxia-Ischemia, Brain/surgeryMPTP Poisoning/pathologyMPTP Poisoning/physiopathologyMaleMiceMice, Inbred C57BLMolecular Chaperones/metabolismNerve Degeneration/etiologyNerve Degeneration/pathologyNerve Degeneration/surgeryNerve Regeneration/physiologyNeural Pathways/pathologyNeurons/drug effectsNeurons/pathologyParkinsonian Disorders/chemically inducedParkinsonian Disorders/pathologyParkinsonian Disorders/physiopathologyParkinsonian Disorders/surgeryPolyglycolic AcidProstheses and ImplantsRecovery of FunctionSignal TransductionStem Cell TransplantationStem Cells/drug effectsStem Cells/pathologyStem Cells/physiologySubstantia Nigra/drug effectsSubstantia Nigra/pathologySubstantia Nigra/physiopathologySubstantia Nigra/surgeryTextilesTyrosine 3-Monooxygenase/metabolism
Substances： See more » Biocompatible MaterialsMolecular Chaperones1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridinePolyglycolic Acid1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineTyrosine 3-MonooxygenaseDextroamphetamine
Year: 2002 PMID： 12410250 DOI： 10.1038/nbt1102-1091
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908